Remedent Reports Fourth Quarter and Year End Results and to Host a Conference Call at 12 PM EDT, Tuesday, July 17, 2012
18 July 2012 - 1:20AM
Marketwired
Remedent, Inc. (OTCBB: REMI), an international company specializing
in research, development, and manufacturing of oral care and
cosmetic dentistry products, reported results for the fourth
quarter and for the year ended March 31, 2012 (in US Dollars).
Conference Call Information:
Remedent will host a conference call on Tuesday, July 17, 2012
at 12:00 p.m. Eastern Daylight Time (9:00 a.m. Pacific Daylight
Time) to discuss these results and its strategic plans for the
future. A question and answer session will follow management's
presentation.
To participate in this call, dial the appropriate number 5-10
minutes prior to the start time. Date: Tuesday, July 17, 2012 Time:
12:00 p.m. Eastern Daylight Time. (9:00 a.m. Pacific Daylight Time)
Dial in Number: 1-888-329-8862
A telephone replay of the call will be available until July 31,
2012 Toll Free Replay Number: 888-2103-1112 Replay Password:
5409163
About Remedent
Remedent, Inc. specializes in the research, development,
manufacturing and marketing of oral care and cosmetic dentistry
products. The company serves professional dental industry with
breakthrough technology for dental veneers. These products are
supported by a line of professional veneer whitening and teeth
sensitivity solutions. Headquartered in Belgium, Remedent
distributes its products to more than 28 countries worldwide. For
more information, go to www.remedent.com.
Forward-Looking Statements
Statements in this press release that are "forward-looking
statements" are based on current expectations and assumptions that
are subject to risks and uncertainties. Such forward-looking
statements involve known and unknown risks, uncertainties and other
unknown factors that could cause Remedent's actual operating
results to be materially different from any historical results or
from any future results expressed or implied by such
forward-looking statements. In addition to statements that
explicitly describe these risks and uncertainties, readers are
urged to consider statements that contain terms such as "believes,"
"belief," "expects," "expect," "intends," "intend," "anticipate,"
"anticipates," "plans," "plan," "projects," "project," to be
uncertain and forward-looking. Actual results could differ
materially because of factors such as Remedent's ability to achieve
the synergies and value creation contemplated by the proposed
transaction. For further information regarding risks and
uncertainties associated with Remedent's business, please refer to
the risk factors described in Remedent's filings with the
Securities and Exchange Commission, including, but not limited to,
its annual report on Form 10-K and quarterly reports on Form 10-Q.
We undertake no duty to revise or update any forward-looking
statements to reflect events or circumstances after the date of
this press release.
Mr. Philippe Van Acker CFO Tel: +32 9 241 58 80
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Elysee Development (PK) (USOTC:ASXSF)
Historical Stock Chart
From Jul 2023 to Jul 2024